FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antje Siegert

Research Profile

Anatomy

Tumor Cells, Cultured

Chemicals & Drugs

Disorders

Physiology

Procedures

Coculture Techniques

Concepts & Ideas

Survival Analysis

Co-author Network

Publications

TOP 3
Carsten Denkert; Antje Fürstenberg; Peter Daniel; Ines Koch; Martin Köbel; Wilko Weichert; Antje Siegert; Steffen Hauptmann
Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.
Carsten Denkert; Klaus-Jürgen Winzer; Berit-Maria Müller; Wilko Weichert; Sören Pest; Martin Köbel; Glen Kristiansen; Angela Reles; Antje Siegert; Hans Guski; Steffen Hauptmann
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
Carsten Denkert; Ines Koch; Stefan Berger; Martin Köbel; Antje Siegert; Steffen Hauptmann
Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antje Siegert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Carsten Denkert; Antje Fürstenberg; Peter Daniel; Ines Koch; Martin Köbel; Wilko Weichert; Antje Siegert; Steffen Hauptmann
Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.
Oncogene 2003;22(54):8653-61.
2003: Carsten Denkert; Klaus-Jürgen Winzer; Berit-Maria Müller; Wilko Weichert; Sören Pest; Martin Köbel; Glen Kristiansen; Angela Reles; Antje Siegert; Hans Guski; Steffen Hauptmann
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.
Cancer 2003;97(12):2978-87.
2003: Carsten Denkert; Ines Koch; Stefan Berger; Martin Köbel; Antje Siegert; Steffen Hauptmann
Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.
Cancer letters 2003;195(1):101-9.
2003: Steffen Hauptmann; Antje Siegert; Stefan Berger; Carsten Denkert; Martin Köbel; Stefan Ott; Annalisa Siri; Laura Borsi
Regulation of cell growth and the expression of extracellular matrix proteins in colorectal adenocarcinoma: a fibroblast-tumor cell coculture model to study tumor-host interactions in vitro.
European journal of cell biology 2003;82(1):1-8.
2002: Carsten Denkert; Wolfgang Schmitt; Stefan Berger; Angela Reles; Sören Pest; Antje Siegert; Werner Lichtenegger; Manfred Dietel; Steffen Hauptmann
Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.
International journal of cancer. Journal international du cancer 2002;102(5):507-13.
2002: Antje Siegert; Christian Rosenberg; Wolfgang Schmitt; Carsten Denkert; Steffen Hauptmann
Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion.
British journal of cancer 2002;86(8):1310-5.
2002: Julia Poland; Pranav Sinha; Antje Siegert; Martina Schnölzer; Ulrike Korf; Steffen Hauptmann
Comparison of protein expression profiles between monolayer and spheroid cell culture of HT-29 cells revealed fragmentation of CK18 in three-dimensional cell culture.
Electrophoresis 2002;23(7-8):1174-84.
2002: Carsten Denkert; Martin Köbel; Sören Pest; Ines Koch; Stefan Berger; Michael Schwabe; Antje Siegert; Angela Reles; Bernd Klosterhalfen; Steffen Hauptmann
Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.
The American journal of pathology 2002;160(3):893-903.
2002: Carsten Denkert; Antje Siegert; Anja Leclere; Andreas Turzynski; Steffen Hauptmann
An inhibitor of stress-activated MAP-kinases reduces invasion and MMP-2 expression of malignant melanoma cells.
Clinical & experimental metastasis 2002;19(1):79-85.
2001: Stefan Berger; Antje Siegert; Carsten Denkert; Martin Köbel; Steffen Hauptmann
Interleukin-10 in serous ovarian carcinoma cell lines.
Cancer immunology, immunotherapy : CII 2001;50(6):328-33.
2001: Carsten Denkert; Martin Köbel; Stefan Berger; Antje Siegert; Anja Leclere; Uwe Trefzer; Steffen Hauptmann
Expression of cyclooxygenase 2 in human malignant melanoma.
Cancer research 2001;61(1):303-8.
1999: Antje Siegert; Carsten Denkert; Anja Leclere; Steffen Hauptmann
Suppression of the reactive oxygen intermediates production of human macrophages by colorectal adenocarcinoma cell lines.
Immunology 1999;98(4):551-6.